SKIN DISEASES
Clinical trials for SKIN DISEASES explained in plain language.
Never miss a new study
Get alerted when new SKIN DISEASES trials appear
Sign up with your email to follow new studies for SKIN DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could ifetroban ease scleroderma lung damage?
Disease control OngoingThis study tests an experimental drug called ifetroban in people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis) or scleroderma-related high blood pressure in the lungs. The goal is to see if the drug is safe and can improve lung function. About 34 adults…
Matched conditions: SKIN DISEASES
Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
AI vs. skin doctors: who diagnoses better?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether artificial intelligence (AI) can give the same skin disease diagnosis as a dermatologist. Researchers will compare diagnoses made by AI and by skin doctors using photos and information sent by general practitioners through a telemedicine platform. The …
Matched conditions: SKIN DISEASES
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated May 26, 2026 05:31 UTC
-
Psoriasis 'Memory' cells targeted in new skin study
Knowledge-focused OngoingThis study looks at whether a combination of a medicated foam (Enstilar®) and narrow-band UVB light can change the 'memory' of psoriasis skin. Psoriasis often returns even after skin looks healed, possibly because certain immune cells (TRM cells) remember the disease. The study i…
Matched conditions: SKIN DISEASES
Phase: PHASE4 • Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC